The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials
- 1 February 2001
- journal article
- review article
- Published by Elsevier in Seminars in Neonatology
- Vol. 6 (1), 63-73
- https://doi.org/10.1053/siny.2000.0036
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Low-dose indomethacin therapy and extension of intraventricular hemorrhage: A multicenter randomized trialThe Journal of Pediatrics, 1994
- Prolonged indomethacin therapy for the prevention of recurrences of patent ductus arteriosusThe Journal of Pediatrics, 1990
- Indomethacin reduces the risks of severe intraventricular hemorrhageThe Journal of Pediatrics, 1989
- Prevention of symptomatic patent ductus arteriosus with a single dose of indomethacinThe Journal of Pediatrics, 1987
- Water balance in very low-birth-weight infants: Relationship to water and sodium intake and effect on outcomeThe Journal of Pediatrics, 1982
- Early closure of the patent ductus arteriosus in very low-birth-weight infants: A controlled trialThe Journal of Pediatrics, 1981
- Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus—a double-blind controlled studyThe Journal of Pediatrics, 1981
- Improved lung compliance after ligation of patent ductus arteriosus in hyaline membrane diseaseThe Journal of Pediatrics, 1978
- Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infantsThe Journal of Pediatrics, 1978
- Closure of the patent ductus arteriosus with ligation and indomethacin: A consecutive experienceThe Journal of Pediatrics, 1978